Project 1: Longitudinal Epidemiology
Tracks epidemiological risk, resilience, and environmental interactions linked to cognitive decline and ADRD progression after SARS-CoV-2 infection.
Explore Project 1: Longitudinal EpidemiologyThe projects examine epidemiology, genetics, neuroimaging, and biomarkers to better understand cognitive decline and Alzheimer’s disease risk after SARS-CoV-2 exposure.
Tracks epidemiological risk, resilience, and environmental interactions linked to cognitive decline and ADRD progression after SARS-CoV-2 infection.
Explore Project 1: Longitudinal EpidemiologyExamines the genetic basis of ADRD-relevant responses to SARS-CoV-2 infection using whole genome sequence data across diverse populations.
Explore Project 2: Gene × Environment InteractionsInvestigates neural signatures of COVID-19-associated cognitive impairment using imaging-based structural and tract-level metrics.
Explore Project 3: NeuroimagingLinks validated blood-brain barrier and related biomarker measures to infection history, brain structure, and brain function.
Explore Project 4: BiomarkersEach project contributes a different layer of evidence. Together, they connect population-level outcomes, biological mechanisms, imaging markers, and genomic variation into one coordinated research program.